Press release
AI in Omics Studies Market Challenges Focus on Data Security and Skilled Workforce Shortage
AI in Omics Studies Market
Global Al in Omics Studies Market Size was valued at USD 823.5 Mn in 2024 and is predicted to reach USD 12505.3 Mn by the year 2034 at a 31.4% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2363
Artificial intelligence (AI) has emerged as a pivotal technology for managing the complexities of omics data analysis, interpretation, and the integration of multi-omics with clinical information. Recent innovations in AI have substantially influenced multiple scientific domains, including drug discovery, disease diagnostics, protein structure prediction, and genetic variant analysis. The AI in omics research market is experiencing sustained growth and is projected to expand significantly over the forecast period.
Key drivers of AI adoption in this sector include its ability to process large and intricate datasets, uncover meaningful patterns, predict biomarkers, and generate novel biological insights. Market expansion is further reinforced by increasing investments in AI technologies and supportive regulatory frameworks. Collectively, these developments are advancing precision medicine and promoting the broader integration of AI solutions within omics research. Consequently, AI is positioned to transform both the field of omics research and the wider healthcare industry, driving global market growth.
List of Prominent Players in the Al in Omics Studies Market
• Thermo Fisher Scientific.
• Agilent Technologies
• Illumina
• BGI Genomics
• Dassault Systemes
• Qiagen
• Waters Corporation
• GE Healthcare
• Amazon Web Services, Inc
• Bruker
• Danaher
• Other Prominent Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics
Drivers:
The AI in omics research market is primarily driven by its transformative potential in genomics and healthcare. The exponential growth and increasing complexity of omics datasets have created a strong demand for advanced analytical tools capable of delivering actionable insights efficiently, positioning AI technologies as an ideal solution. Additionally, the expanding focus on personalized medicine and targeted therapeutic development necessitates AI-enabled methods for precise biomarker identification and innovative drug discovery. Strategic partnerships among academic institutions, industry leaders, and healthcare organizations further accelerate innovation and facilitate the seamless integration of AI solutions in omics research.
Challenges:
Despite its growth potential, the AI in omics research sector faces several challenges. Concerns surrounding data privacy and security remain a significant barrier to widespread adoption. Moreover, the shortage of skilled AI professionals, coupled with the complex nature of AI systems in genomics, limits effective integration into existing workflows. Stringent regulatory frameworks governing data security, privacy, and ethical compliance further complicate the deployment of AI technologies, posing additional constraints on market expansion.
Regional Trends:
As of 2023, North America dominated the global AI in omics market, capturing a significant revenue share. This leadership is supported by the presence of major industry players, including Google Health, Danone, Abbott, Nestlé, IBM, and Targeted Medical Pharma, Inc., alongside well-funded research institutions and biotechnology firms investing heavily in AI-driven genomics solutions. Concurrently, the Asia-Pacific region is projected to witness rapid growth, fueled by a large population base, rising adoption of precision medicine and genomics technologies, and increasing healthcare expenditures, collectively driving demand for AI-based genomics applications in the region.
Recent Developments:
• In November 2023, biotechnology companies OWKIN and 10x Genomics, Inc., jointly announced that they have reached an agreement to incorporate 10x Genomics' single-cell and spatial omics technologies to their work in tumour investigation for potential therapeutic targets.
• In September 2023, Janssen Global Services, LLC, a pharmaceutical firm, and Intelligent OMICS Ltd., a biotechnology company, agreed to a partnership in AI-driven research. The goal of the partnership with Janssen Global Services, LLC is to identify new biological targets that can be used to treat haematological malignancies.
• in June 2022, the Ultima Genomics firm and Nvidia announced that they are partnering to separate AI at various stages of the DNA sequencing and analysis process. Accelerating variant calling and deep learning in photometry and base calling are two aspects of the relationship.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2363
Segmentation of Al in Omics Studies Market -
By Offering:
• Software
• Services
By Technology Platform:
• Sequencing
• Epigenomics
• Proteomics
• Metabolomics
• Others (Transcriptomics, among others)
By Application:
• Oncology
• Infectious Diseases
• Neurology
• Cardiovascular Diseases
• Immunology
• Others (Pharmacogenomics, among others)
By End User:
• Academic and Research Institutes
• Biopharmaceutical Company
• Others (Contract Research Organizations, among others)
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/ai-in-omics-studies-market/2363
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Omics Studies Market Challenges Focus on Data Security and Skilled Workforce Shortage here
News-ID: 4312713 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Syringe Filter Market Analysis Highlights Increasing Adoption Across Laboratorie …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Syringe Filter Market Size, Share & Trends Analysis Report By Filter Material (Polytetrafluoroethylene (PTFE), Polyvinylidene Difluoride (PVDF), Nylon), Pore Size (Sub-Micron Filters, Microfilters), Application (Pharmaceuticals, Biotechnology, Food and Beverage, Environmental Analysis), End User (Laboratories, Research Institutions, Pharmaceutical Companies, Biotechnology Companies) , Region, Market Outlook And Industry Analysis 2034"
The Global Syringe Filter Market is estimated to…
Packaging 4.0 Market Analysis Emphasizes Smart, Sustainable, and Anti-Counterfei …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Packaging 4.0 Market Size, Share & Trends Analysis Report By Type (Active, Smart, Sustainable, Protective, Supply Chain Management, And Anti-Counterfeiting Packaging), Technology (IoT, RFID, AI, AR), Material (Biodegradable And Compostable Materials, Recyclable Plastics), And End-User (food and beverage, pharmaceuticals and healthcare, cosmetics and personal care, automotive and industrial, retail and consumer goods, and agriculture and…
Digital Twins in Healthcare Market Dynamics Focus on Drug Discovery and Surgery …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Twins in Healthcare Market - (By Component (Software, Services), By Application (Drug Discovery & Development, Personalized medicine, Surgical Planning and Medical Education, Medical Device Design and Testing, Healthcare Workflow Optimization & Asset Management, Others), By End User (Pharma & Bio-pharma companies, Research & Academia, Providers, Medical device Companies, Others)), Trends, Industry Competition Analysis, Revenue…
Electronic Bill of Lading Market Insights Emphasize Cloud and On-Premise Solutio …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Bill of Lading Market - (By Functionality (Document Management, Electronic Signature, Integration Capabilities, and Compliance and Security Features), By End-use Industries (Manufacturing, Logistics and Transportation, Retail, Healthcare, and Others), By Deployment Type (Cloud-based eBL Software and On-premise eBL Software)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce…
More Releases for Omics
Single-Cell Omics Market to Reach USD 10.74 Billion by 2030 as Multi-Omics & Pre …
Sub-Headline: The global Single-Cell Omics Market is expected to grow from USD 4.12 billion in 2023 to USD 10.74 billion by 2030, registering a robust CAGR of 14.6%, driven by rapid advances in single-cell sequencing, spatial omics, immunology research, and multi-omics integration.
Introduction
The Single-Cell Omics Market is undergoing explosive expansion as researchers seek deeper insights into cellular diversity, gene expression variability, epigenetic signatures, and molecular activity at single-cell resolution. Unlike bulk…
Emerging Single-Cell Omics Market Trends: Product Innovation Marks A Milestone I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Single-Cell Omics Market Size Growth Forecast: What to Expect by 2025?
The size of the single-cell omics market has experienced rapid expansion in the last few years. From the year 2024 to 2025, an increase from $2.08 billion to $2.39 billion is projected, with an anticipated compound annual growth…
Rising Cancer Prevalence Propels Growth In The Single-Cell Omics Market: An Emer …
The Single-Cell Omics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Single-Cell Omics Market?
In recent times, there has been a significant expansion in the size of the single-cell omics market. It is predicted to increase from $2.08 billion…
Rising Prevalence Of Genetic Illnesses Drives Growth Of The Spatial Omics Market …
What combination of drivers is leading to accelerated growth in the spatial omics market?
The rising prevalence of genetic disorders is expected to drive the spatial omics market. Genetic diseases are caused by abnormalities in DNA and are increasing due to better awareness and diagnostic technologies. Spatial omics provides in-depth molecular and genetic maps, helping study these disorders. For instance, the World Health Organization (WHO) estimated that congenital diseases caused 240,000…
Prominent Single-Cell Omics Market Trend for 2025: Product Innovation Marks A Mi …
What industry-specific factors are fueling the growth of the single-cell omics market?
The escalation in the occurrence of cancer is forecasted to boost the expansion of the single-cell omics market in the future. Cancer includes various diseases that occur when irregular cells multiply uncontrollably, overstep their usual limits, and either metastasize to other organs or infiltrate nearby body parts in almost any organ or tissue. The detection of biomarkers for cancer…
Charnwood Discovery and Intelligent Omics Announce Strategic Collaboration
Charnwood Discovery a leading drug discovery research partner has announced a strategic collaboration with Intelligent OMICS Ltd (Intellomx) who specialise in applying artificial intelligence (AI) and Machine Learning (ML) to accelerate drug discovery.
The collaboration will enable Charnwood Discovery to enhance its already extensive drug discovery services through Intellomx's AI platform which enables the identification of previously unattainable targets.
Dr Francesca Sadler, Charnwood Discovery's Chief Commercial Officer commented:
"This exciting collaboration…
